[{"innerBlocks":[],"name":"core\/freeform","postId":2607,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"A new company formed out of an integrated innovation enterprise whose anchor investor is the American Medical Association hopes to build a network as a service platform that will use blockchain technology to move healthcare information.

Akiri, based in San Francisco, is working on using information technology to develop its platform to securely share information with participants, using the capabilities of blockchain to build a network of trusted partners to exchange data.

Blockchain is a distributed ledger technology implemented in a decentralized manner used to record transactions.
The records are kept across many computers such that data cannot be altered retroactively.

Akiri Switch will be a vendor-agnostic solution using software-defined network (SDN) and secure routing protocol technology optimized for healthcare data. It employs blockchain technology to help securely transmit information.

Also See<\/b>: Luna DNA gets seed money to fund blockchain initiative<\/a>

Akiri identifies securing, sharing and using trusted health data in real time as a key challenge in healthcare. It calls its network-as-a-service offering Akiri Switch and it aims \u201cto create a 360-degree network of trust\u201d in which only subscribers to the network can share health data using the network.

The 240,000-member AMA is the first identified participant, and Akiri says Celgene, the global pharmaceutical company, is also collaborating.

Executives believe that Akiri Switch will secure and simplify the IT infrastructure for provider organizations, transmitting information through its trusted network architecture. For physician participants, the network could enable the use of technologies that can help build doctor-patient relationships.

Akiri Switch won\u2019t function as a health information exchange or an extract, transform, load (ETL) process. It\u2019s described as \u201can invitation-only, subscription-based, ultra-secure private network.\u201d Executives say applications also can be developed and validated to run on its infrastructure.

With its start in the AMA-supported Health2047 innovation center, Akiri received $10 million Series A investment, it has built out its team with engineering talent, attracting staff from Apple, Cisco, GE Healthcare, Stanford, VMWare and others, executives say.

\u201cAkiri is positioned to support security, identification, authentication, compliance, analytics and applications,\u201d says Adriaan Ligtenberg, Akiri\u2019s CEO. \u201cAkiri Switch verifies healthcare data sources and destinations, allowing trusted applications to be developed and validated for patients, physicians, providers, pharma, payers and other healthcare enterprises.\u201d

\u201cWe must advance and embrace new technologies that have the potential to create truly meaningful market impact at the system level,\u201d said James L. Madara, MD, the AMA\u2019s CEO. \u201cThe data liquidity problem that physicians and other healthcare stakeholders currently face needs to be solved because it\u2019s one of the biggest barriers to improving the patient-physician relationship.\u201d","saveContent":"A new company formed out of an integrated innovation enterprise whose anchor investor is the American Medical Association hopes to build a network as a service platform that will use blockchain technology to move healthcare information.

Akiri, based in San Francisco, is working on using information technology to develop its platform to securely share information with participants, using the capabilities of blockchain to build a network of trusted partners to exchange data.

Blockchain is a distributed ledger technology implemented in a decentralized manner used to record transactions.
The records are kept across many computers such that data cannot be altered retroactively.

Akiri Switch will be a vendor-agnostic solution using software-defined network (SDN) and secure routing protocol technology optimized for healthcare data. It employs blockchain technology to help securely transmit information.

Also See<\/b>: Luna DNA gets seed money to fund blockchain initiative<\/a>

Akiri identifies securing, sharing and using trusted health data in real time as a key challenge in healthcare. It calls its network-as-a-service offering Akiri Switch and it aims \u201cto create a 360-degree network of trust\u201d in which only subscribers to the network can share health data using the network.

The 240,000-member AMA is the first identified participant, and Akiri says Celgene, the global pharmaceutical company, is also collaborating.

Executives believe that Akiri Switch will secure and simplify the IT infrastructure for provider organizations, transmitting information through its trusted network architecture. For physician participants, the network could enable the use of technologies that can help build doctor-patient relationships.

Akiri Switch won\u2019t function as a health information exchange or an extract, transform, load (ETL) process. It\u2019s described as \u201can invitation-only, subscription-based, ultra-secure private network.\u201d Executives say applications also can be developed and validated to run on its infrastructure.

With its start in the AMA-supported Health2047 innovation center, Akiri received $10 million Series A investment, it has built out its team with engineering talent, attracting staff from Apple, Cisco, GE Healthcare, Stanford, VMWare and others, executives say.

\u201cAkiri is positioned to support security, identification, authentication, compliance, analytics and applications,\u201d says Adriaan Ligtenberg, Akiri\u2019s CEO. \u201cAkiri Switch verifies healthcare data sources and destinations, allowing trusted applications to be developed and validated for patients, physicians, providers, pharma, payers and other healthcare enterprises.\u201d

\u201cWe must advance and embrace new technologies that have the potential to create truly meaningful market impact at the system level,\u201d said James L. Madara, MD, the AMA\u2019s CEO. \u201cThe data liquidity problem that physicians and other healthcare stakeholders currently face needs to be solved because it\u2019s one of the biggest barriers to improving the patient-physician relationship.\u201d","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Akiri to offer blockchain platform to securely share data

More for you